growth focu preview
view expect report line estim
adjust eps/revenu street given stabl
demand note fx sale certegi check busi may
creat headwind
topic quarter question quarter includ organ
growth disappoint last quarter impact
chang time revenu recognit licens renew
margin expans underli demand especi gf
channel brexit-expos bank chang guidanc look
integr financi solut if forecast
adjust organ y/i revenu increas if revenu
reach ebitda margin if
organ revenu growth versu previou quarter
gener reflect mix cost initi if ebitda margin
expand y/i adjust basi previou quarter
forecast
global financi solut gf forecast gf revenu
organ growth ebitda
sharp deceler previou quarter adjust ebitda
margin expand y/i last quarter mix
oper improv synergi divestitur estim
forecast accord compani
organ growth declin stem
relat time differ licens renew revers
especi declin furthermor stem
client opt outsourc deal decreas revenu
near term improv visibl
possibl guidanc tweak sale check fx given fx
check divestitur would surpris manag
tweak current guidanc call organ revenu growth
consolid revenu declin
adjust ebitda margin adjust ep
revenu pleas note re-stat
remain origin report
ep cash dilut pleas note
re-stat remain origin
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
believ compani focu turn acceler
revenu growth balanc margin especi given
focu larger transform deal global f/i
channel opinion compani intern exposur
repres competit advantag especi deal size
appear increas fintech spend becom
strateg els equal posit trend continu
believ multipl expans possibl futur
near term compani could face pressur
macro-environ increas competit
time differenti given shift larger integr
contract risk associ exposur big
near-term potenti catalyst includ improv
expans project ramp global f/i channel
impact fintech innov mobil real-tim
network cross-sel sungard acquisit
bloomberg capit market estim upside/downside/target
price target roughli
ep estim line histor averag
discount target multipl closest competitor
given organ growth execut differ underli
ep estim expect organ growth
mid-singl digit base low-single-digit growth overal
bank tech spend price target support outperform
upsid scenario valuat upsid
ep estim premium current estim
one-point premium target multipl believ
appropri earn surpris upsid
upsid potenti assum acceler organ growth
high-singl digit driven increas bank technolog
spend fidel client win end
potenti intern demand perhap form
larg contract oper leverag
downsid scenario valuat base
downsid ep estim discount current estim
five-point reduct target multipl
believ appropri earn surpris downsid
would call question stabil compani
potenti assum deceler organ growth driven
whether fidel client lose end potenti
matter quarter
expect report line estim adjust ep revenu
street given stabl demand note fx sale
certegi check busi may creat headwind septemb sold certegi
check servic term announc note time belief
talk manag transact would dilut ep
adjust estim accordingli uncertain whether street
fulli adjust estim addit gener revenu outsid
us meaning exposur brazilian euro gbp estim
current guidanc includ headwind revenu fx greatest
exposur quarter compani schedul report result tuesday
octob market open host confer call et
may add due round prior year restat
question quarter includ
organ growth disappoint last quarter impact chang
time revenu recognit licens renew revers
margin expans expect rel flat comparison termin fee
underli demand especi gf channel brexit-expos bank
chang guidanc look driver chang includ fx
divestitur certegi check wind-down bradesco joint ventur
organ growth overal oper margin
reflect divestitur effect adopt expect total
revenu declin y/i report basi restat last year
result chang account total compani organ revenu growth
deceler y/i prior quarter organ growth acceler if
deceler gf manag
note declin stem chang revenu recognit
time guid organ growth unit
entir compani includ headwind segment includ
divest check busi
reflect oper leverag divestitur anticip y/i ebitda
margin expans restat prior year result account
forecast y/i revenu increas if revenu
reach ebitda margin if organ revenu
growth versu previou quarter unit saw modest deceler
bank wealth organ growth revers payment organ revenu
increas versu declin previous adopt volum increas
acceler corpor digit organ growth previous gener
reflect mix cost initi if ebitda margin expand y/i
adjust basi previou quarter forecast
exhibit integr financi solut revenu left ebitda right
forecast gf revenu organ growth ebitda
margin gf organ revenu growth declin y/i sharp
deceler previou quarter deceler organ growth
institut wholesal versu previous bank payment busi
also deceler adjust ebitda margin expand y/i
last quarter mix oper improv synergi divestitur
estim forecast accord compani
organ growth declin stem time
differ licens renew revers especi
declin furthermor stem client opt outsourc deal
decreas revenu near term improv visibl
exhibit global financi solut revenu left ebitda right
guidanc sale check
given fx check divestitur would surpris manag tweak
current guidanc call organ revenu growth consolid
revenu declin adjust ebitda margin adjust ep
price target roughli ep estim line histor
averag discount target multipl closest competitor given organ
growth execut differ underli ep estim expect organ
growth mid-singl digit base low-single-digit growth overal bank tech spend
price target support outperform rate
risk rate price target
lack growth bank spend contempl model inabl
cross-sel new product could imped price target object rate continu
consolid bank failur prolong global recess could caus stock perform
expect imped achiev price target object rate
lead provid technolog solut process servic information-bas
servic financi servic industri compani process technolog
relationship custom countri custom rang
larg financi institut small credit union
ep model million except per share amount
total
total
corpor
compani data capit market estim ep exclud purchas amort non-cash expens
